Blake Aftab

CIK: 0001886986

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACET

Adicet Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ACET
Adicet Bio, Inc.
Jun 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
55K shares-
ACET
Adicet Bio, Inc.
Mar 25, 2026
Award(A)
Stock Option (Right to Buy)
Direct
72.6K shares-
ACET
Adicet Bio, Inc.
Jan 24, 2026
Tax Payment(F)
Direct
535 shares at avg. $8.44$5K
ACET
Adicet Bio, Inc.
Jan 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
275K shares-
ACET
Adicet Bio, Inc.
Jan 24, 2025
Tax Payment(F)
Direct
6.3K shares at avg. $0.92$6K

		Type	Shares	Price		Ownership
Jun 19, 2026	ACET Adicet Bio, Inc.	Award(A) Stock Option (Right to Buy)	55,000	-	-	Direct
Mar 25, 2026	ACET Adicet Bio, Inc.	Award(A) Stock Option (Right to Buy)	72,555	-	-	Direct
Jan 24, 2026	ACET Adicet Bio, Inc.	Tax Payment(F)	535	$8.44	$4,515	Direct
Jan 31, 2025	ACET Adicet Bio, Inc.	Award(A) Stock Option (Right to Buy)	275,000	-	-	Direct
Jan 24, 2025	ACET Adicet Bio, Inc.	Tax Payment(F)	6,270	$0.92	$5,780	Direct

1-5 of 5 transactions

About Aftab Blake

Aftab Blake (SEC CIK 0001886986) files insider reports with the SEC as Chief Scientific Officer of Adicet Bio, Inc. (ACET).

Signal8 holds 5 ownership filings by Aftab Blake, all Form 4s, filed between Jan 28, 2025 and Jun 23, 2026. Those filings report 5 transactions, from Jan 24, 2025 to Jun 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Aftab Blake's filings is in BOSTON, MA.

Recent filings by Aftab Blake

Jun 19, 2026: Grant or award of ACET derivative securities (Form 4, code A).
Mar 25, 2026: Grant or award of ACET derivative securities (Form 4, code A).
Jan 24, 2026: Tax withholding of ACET shares (Form 4, code F).
Jan 31, 2025: Grant or award of ACET derivative securities (Form 4, code A).
Jan 24, 2025: Tax withholding of ACET shares (Form 4, code F).

Other insiders filing for Adicet Bio, Inc. (ACET)

Klickstein Lloyd, Chief Medical Officer
Schor Chen, President & CEO
DUBIN STEVE, Director
Chodakewitz Jeffrey, Director
Grissinger Michael, Director
Sinclair Andrew, Director

How to read Form 4 transaction codes